Make time for self-care
There is so much to consider as a caregiver to someone with Alzheimer’s. As Alzheimer’s progresses, your role as a caregiver changes as well.
A helpful resource from the Alzheimer’s Association helps to shed some light on the various aspects of care-giving, including making sure to make time for self-care as well.
Head device reduces memory loss in 7 out of 8 people
🔬🧠Recent research involving eight Alzheimer’s patients found that a new wearable device emitting electromagnetic impulses was able to significantly improve memory loss in seven of these participants within two months.🧠🔬
Researchers worked with the participants with mild to moderate Alzheimer’s disease and their caretakers. The participants wore the device twice a day for two months, with each session lasting one hour.
At the end of the two months, none of the participants had experienced any side effects. The investigators also used The Alzheimer’s Disease Assessment Scale-Cognitive Subscale test (ADAS-cog), the most widely recognized method of assessing cognitive function. It was found that seven of the eight participants saw an increase of over 4 points in cognitive performance on the ADAS-cog scale after two months. According to the researchers, it is as if the participants’ cognitive function had “rejuvenated” by a year.
While far more research is needed regarding the device, scientists are encouraged by these preliminary findings. It is reported that another trial is due to last around 17 months, on average, and will include about 150 participants with a diagnosis of mild to moderate Alzheimer’s disease. The findings from this study have been published in the Journal of Alzheimer’s Disease.
A clinical trial has found that an innovative electromagnetic therapy device significantly reduced memory loss in seven out of the eight participants.
Frontotemporal dementia: Devastating, prevalent and little understood
A recent article and interview from 60 Minutes discusses frontotemporal dementia, or FTD.
FTD is the number one form of dementia in Americans under the age of 60. The causes of this condition are unclear.
The condition attacks the frontal and temporal lobes of the brain, the areas controlling personality and speech. Individuals will either display such uncharacteristic behavior that their loved ones can hardly recognize them, or they lose the ability to recognize themselves.
Bill Whitaker reports on FTD, a devastating illness and the most common form of dementia for Americans under the age of 60
Dr. Oz's Mother Has Alzheimer's: I'm Feeling Guilty Because I Completely Missed the Signs
Dr. Oz recently shared that his mother has been diagnosed with Alzheimer’s.
A recent article from People shares some of the details regarding her diagnosis.
The host of The Dr. Oz Show also learned that he carries one of the genes for Alzheimer’s
Me and Momma 2014
💌We’ve received another touching moment from one of our community members. 💌
“This is my most cherished memory with my momma. I’m the youngest of 4 and the only girl. She was my best friend and I miss her every day. She put up a hard fight for 8 years. We lost her on 7/9/2015.”
Me and Momma 2014
Could targeting variants of this gene help fight Alzheimer's disease?
Researchers have identified gene variants that appear to be able to alter the risk of Alzheimer’s disease by changing levels of a protein that is present in cerebrospinal fluid.
It was found that variants in the MS4A4A gene influence the risk of both early and late onset Alzheimer’s disease. These variants alter levels of the TREM2 protein, which helps the brain to clear away excess amyloid and tau. Buildup of amyloid and tau are hallmarks of Alzheimer’s disease.
It is hoped that this information can help to the development of a way to increase the levels of TREM2 in cerebrospinal fluid in an effort to help protect against Alzheimer’s disease or slow the development. The findings have been published in Science Translational Medicine.
Researchers have found variants of a gene that influence Alzheimer’s disease risk through their effect on a cerebrospinal fluid protein.
Too Much Napping May Signal Alzheimer's
Recent research shows that excessive napping may be an early sign of Alzheimer’s disease.
Researchers have found that the areas of the brain that keep you awake during the day are damaged in the early stages of Alzheimer’s, which is why those with the condition may nap excessively long before they start to forget things. Further, the scientists also found that damage to those brain regions was caused by the protein tau. This gives more evidence that tau may play a larger role in Alzheimer’s than the amyloid protein.
The findings were recently published in the journal Alzheimer’s and Dementia.
Areas of the brain that keep you awake during the day are damaged in the early stages of the memory-robbing disease, which is why people with Alzheimer’s may nap excessively long before they start to struggle with forgetting things, the study authors said.
Could a blood test help predict the development of Alzheimer's?
Scientists at the Washington University used mass spectrometry to measure amounts of two types of amyloid beta in the blood: amyloid beta 40 and 42.
They found the ratio of these types in the blood goes down as the amount of the substance in the brain increases. The new test may be able to warn of amyloid deposits forming years before they can be identified by PET scans.
When combined with risk factor evaluation, the test is said to have a 94 percent accuracy. It is hoped that early detection will allow people to take action to slow down disease progression.
The findings have been published in Neurology.
Alzheimer's: Common gene explains why some drugs fail
Recent research shows that a certain gene may explain why some Alzheimer’s drugs work in certain people but may fail in others.
The gene is called CHRFAM7A, and it is specific to humans, though only 75% of people have it. It is a fusion gene, a fusion between a gene that encodes a receptor for the neurotransmitter acetylcholine, and a type of enzyme called a kinase. Acetylcholine plays a key role in memory and learning, and researchers have long linked it with the development of Alzheimer’s.
Further research is needed to understand this concept, but researchers hope this can help pave the way to more personalized approach toward treating Alzheimer’s. The findings were presented at the Alzheimer’s Association International Conference, which took place in Los Angeles, CA.
A new study helps to explain why some Alzheimer’s drugs work in some people but not in others, and why some yet may succeed in animals but not in humans.
New clues on why women's Alzheimer's risk differs from men's
Researchers have found differences in how tau, a protein that forms tangles that destroy nerve cells, spreads in the brains of women compared to men.
Scientists at Vanderbilt University studied scans on 301 people with normal thinking skills and 161 others with mild impairment. They mapped the tau deposits and correlated them with nerve networks. It was found that tau networks in women with mild impairment were more spread out, suggesting that more areas of the brain were affected.
Further research is needed to understand the differences in disease progression among females and males. The study findings were presented this week at the Alzheimer’s Association International Conference in Los Angeles, California.
Two-thirds of Alzheimer’s cases in the United States are in women, and it’s not just because women live longer, experts say.
After multiple failures, Alzheimer's researchers turn their attention to inflammation
Researchers are beginning to focus their efforts on targeting brain inflammation in an effort to help treat Alzheimer’s. A recent article from NBC discusses these current efforts.
The past decade of Alzheimer’s disease research has been fraught with disappointment. But some scientists say they’re more hopeful than ever a cure will be found.
Hypertension treatment may slow down Alzheimer's progression
Results from a small study published in the journal Hypertension show that a drug used to treat hypertension may help to improve blood flow to the brain in patients with Alzheimer’s.
It is emphasized that more research is needed across larger groups and for longer periods of time to fully understand the potential benefits.
New research finds that nilvadipine, a drug doctors commonly use to treat high blood pressure, increases the blood flow to the brain’s hippocampus.
This Is A Major Misconception About Caring For Someone With Alzheimer's
A recent article from Women’s Health shares “12 Things No One Tells You About Alzheimer’s.”
Each one comes from either a medical professional or a caregiver, and ranges from the ability to still have meaningful relationships, to exercise, progression, and more.
What’s one thing you would add to the list? Share below!
So someone you love was diagnosed…now what?
Possible Alzheimer's prevention breakthrough reported
Researchers from the University of New Mexico are testing a possible vaccine they developed to help prevent Alzheimer’s disease.
The vaccine has been tested on groups of mice with Alzheimer’s. The vaccine targets pathological tau, a protein commonly found in the brains of Alzheimer’s patients. The vaccine appears to have cleared out the pathological tau in the mice tested.
More research is needed to continue developing the vaccine, in addition to human trials.
University of New Mexico researchers say they’ve apparently found way to prevent formation of brain protein instrumental in disease’s development
ALZHEIMER'S DISEASE FROM MY PERSPECTIVE | Marieta Kysel | TEDxYouth@ECP
Marieta is a 16-year-old who grew up in Morava and spent most of her early childhood with her grandmother. In her TED talk, Marieta discusses what her grandmother’s journey with Alzheimer’s has taught her.
Marieta is a 16-year-old ECP student who grew up in Morava and spent most of her early childhood in her grandmother’s company. When she was told her grandmot…